ARKG vs. LFSC

Last updated Apr 1, 2026

Compare and contrast key facts about ARK Genomic Revolution Multi-Sector ETF (ARKG) and F/m Emerald Life Sciences Innovation ETF (LFSC).

ARKG and LFSC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. ARKG is an actively managed fund by ARK. It was launched on Oct 31, 2014. LFSC is an actively managed fund by F/m Investments. It was launched on Oct 30, 2024.

Performance

ARKG vs. LFSC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and F/m Emerald Life Sciences Innovation ETF (LFSC). The values are adjusted to include any dividend payments, if applicable.

ARKG vs. LFSC - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ARKG ARK Genomic Revolution Multi-Sector ETF	-8.80%	23.04%	1.75%
LFSC F/m Emerald Life Sciences Innovation ETF	-4.45%	56.54%	-6.02%

Returns By Period

In the year-to-date period, ARKG achieves a -8.80% return, which is significantly lower than LFSC's -4.45% return.

ARKG

• 1D: 6.45%
• 1M: -11.87%
• YTD: -8.80%
• 6M: -4.86%
• 1Y: 27.26%
• 3Y*: -4.22%
• 5Y*: -21.56%
• 10Y*: 4.69%

LFSC

• 1D: 6.16%
• 1M: -3.82%
• YTD: -4.45%
• 6M: 17.66%
• 1Y: 55.83%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. LFSC - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is higher than LFSC's 0.54% expense ratio.

ARKG

ARK Genomic Revolution Multi-Sector ETF

LFSC

F/m Emerald Life Sciences Innovation ETF

Return for Risk

ARKG vs. LFSC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG

ARKG Risk / Return Rank: 36
ARKG Sharpe Ratio Rank: 35
ARKG Sortino Ratio Rank: 46
ARKG Omega Ratio Rank: 35
ARKG Calmar Ratio Rank: 35
ARKG Martin Ratio Rank: 29

LFSC

LFSC Risk / Return Rank: 86
LFSC Sharpe Ratio Rank: 89
LFSC Sortino Ratio Rank: 90
LFSC Omega Ratio Rank: 82
LFSC Calmar Ratio Rank: 91
LFSC Martin Ratio Rank: 79

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. LFSC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and F/m Emerald Life Sciences Innovation ETF (LFSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ARKG	LFSC	Difference
Sharpe ratio Return per unit of total volatility	0.61	1.93	-1.31
Sortino ratio Return per unit of downside risk	1.19	2.65	-1.46
Omega ratio Gain probability vs. loss probability	1.13	1.33	-0.20
Calmar ratio Return relative to maximum drawdown	0.82	3.20	-2.38
Martin ratio Return relative to average drawdown	2.22	8.96	-6.74
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ARKG vs. LFSC - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 0.61, which is lower than the LFSC Sharpe Ratio of 1.93. The chart below compares the historical Sharpe Ratios of ARKG and LFSC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ARKG	LFSC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.61	1.93	-1.31
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.48	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.11	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.08	0.94	-0.87

Correlation

The correlation between ARKG and LFSC is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

ARKG vs. LFSC - Dividend Comparison

Neither ARKG nor LFSC has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%
LFSC F/m Emerald Life Sciences Innovation ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

ARKG vs. LFSC - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than LFSC's maximum drawdown of -29.74%. Use the drawdown chart below to compare losses from any high point for ARKG and LFSC.

Drawdown Indicators

	ARKG	LFSC	Difference
Max Drawdown Largest peak-to-trough decline	-83.59%	-29.74%	-53.85%
Max Drawdown (1Y) Largest decline over 1 year	-27.51%	-16.25%	-11.26%
Max Drawdown (5Y) Largest decline over 5 years	-80.18%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-83.59%	—	—
Current Drawdown Current decline from peak	-76.36%	-11.08%	-65.28%
Average Drawdown Average peak-to-trough decline	-35.30%	-8.25%	-27.05%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.16%	5.80%	+4.36%

Volatility

ARKG vs. LFSC - Volatility Comparison

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 13.28% compared to F/m Emerald Life Sciences Innovation ETF (LFSC) at 10.35%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than LFSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARKG	LFSC	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.28%	10.35%	+2.93%
Volatility (6M) Calculated over the trailing 6-month period	31.86%	19.97%	+11.89%
Volatility (1Y) Calculated over the trailing 1-year period	44.94%	29.24%	+15.70%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.37%	29.31%	+16.06%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.94%	29.31%	+11.63%